We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Alimera Sciences Inc | NASDAQ:ALIM | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 3.57 | 1.44 | 5.66 | 0 | 09:16:45 |
From May 2019 to May 2024
Mr. Eiswirth’s presentation will be held at 2:00 PM PT in Room 9 of the Beverly Hilton Hotel, 9876 Wilshire Blvd. in Beverly Hills, Calif. Investors interested in one-on-one meetings should contact the conference organizers at conference@brileyfbr.com.
About Alimera Sciences, Inc.
www.alimerasciences.com
Alimera, founded in June 2003, is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals. Alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and will affect millions of people in our aging populations. For more information, please visit www.alimerasciences.com.
| For Investor Inquiries: Scott Gordon for Alimera Sciences scottg@coreir.com | For press inquiries:Jules Abrahamfor Alimera Sciences 917-885-7378julesa@coreir.com |
1 Year Alimera Sciences Chart |
1 Month Alimera Sciences Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
